FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Teligent Pharma Betamethasone Dipropionate Lotion Recall

Betamethasone Dipropionate Lotion USP, 0

Teligent Pharma, Inc. · Buena, NJ

Risk level
Class II
Reported by FDA
Mar 30, 2022
Recall ID
D-0669-2022
Check your lot numberHow we source this data

Summary

Teligent Pharma recalled Betamethasone Dipropionate Lotion starting Mar 15, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0669-2022 on Mar 30, 2022. Reason: cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. Status: Terminated.

Why it was recalled

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Product description

Betamethasone Dipropionate Lotion USP, 0.05%* (Augmented), packaged in a) 30 mL (29 grams) bottles, NDC 52565-023-29; b) 60 mL (58 grams) bottles, NDC 52565-023-59, Rx Only, Teligent Pharma, Inc., Buena, NJ 08310

Lot numbers, UPCs & expiration codes

Batch: a) 15998, Exp. 3/31/2022; b) 16104, Exp. 4/30/2022; 16133, Exp. 5/31/2022; 16391, Exp. 8/31/2022; 15440, Exp. 9/30/2022

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0669-2022
Classification
Class II
Status
Terminated
Recall initiated
Mar 15, 2022
FDA report date
Mar 30, 2022
Quantity
43,218 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Teligent Pharma, Inc.

Original FDA data

Every field from FDA enforcement report D-0669-2022, exactly as published.

Show all FDA fields
City
Buena
State
NJ
Status
Terminated
Country
United States
Event ID
89798
Address
105 Lincoln Avenue
Code information
Batch: a) 15998, Exp. 3/31/2022; b) 16104, Exp. 4/30/2022; 16133, Exp. 5/31/2022; 16391, Exp. 8/31/2022; 15440, Exp. 9/30/2022
Postal code
08310
Report date
Mar 30, 2022
Product type
Drugs
Recall number
D-0669-2022
Classification
Class II
Recalling firm
Teligent Pharma, Inc.
Product quantity
43,218 bottles
Termination date
Jun 17, 2024
Reason for recall
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Betamethasone Dipropionate Lotion USP, 0.05%* (Augmented), packaged in a) 30 mL (29 grams) bottles, NDC 52565-023-29; b) 60 mL (58 grams) bottles, NDC 52565-023-59, Rx Only, Teligent Pharma, Inc., Buena, NJ 08310
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Mar 15, 2022
Initial firm notification
Letter
Center classification date
Mar 21, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0669-2022, published Mar 30, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls